Home > Formulary : Adult > Recent Decisions > 2017 >
Decisions 28th November 2017
At the meeting on the 28th November the following decisions were agreed:
New Drug Requests
Approved
Ulipristal (TLS green)
- Approved for inclusion onto the formulary for hormonal emergency contraception
Ganciclovir eye gel (TLS blue)
- Approved for inclusion onto the formulary for acute herpetic keratitis
Ceftazidime/avibactam (TLS Red)
- Approved for inclusion onto the formulary on the advice of microbiology for proven multi-drug resistant gram-negative pathogens most likely carbapenem resistant enterobacteriaceae due to KPC or OXA-48 B.lactamases
Betnesol-N® (TLS green)
- Approved for inclusion onto the formulary for treatment of otitis externa
Shared Care Protocols/TLS change in Status
Degarelix®
- New SCP, clarification regarding monitoring required
Dymista
- Further information required for change TLS amber to green
Lidocaine 5% transdermal Patch (TLS Red to Amber)
- Change of TLS from red to amber (No SCP) agreed
Cabergoline and bromocriptine
- New SCP, approved
Penicillamine
- Updated SCP and advise sheet approved
Gold
- Updated SCP and advise sheet approved
Other
Iron preparations
- JFG agreed that trusts can decide locally on which preparation are the most cost effective to use in specific clinical situations.